Skip to main content
Equibles

Allianz Asset Management GmbH

Position in ABBV — AbbVie Inc.

CIK 1535323 MUNICH, 2M
Back to ABBV Full portfolio

Position in ABBV

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$303,167,574
+$15,447,712 QoQ
Shares Held
1,393,938
+10.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 85.8781380520511.ToString("F0")% Shared 0.ToString("F0")% None 14.121861947948904.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2026
CallValue
$18,617,144
CallShares
85,600
PutValue
$27,969,214
PutShares
128,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Allianz Asset Management GmbH holds $5,105,423,958 across 13 Drug Manufacturers - General names. ABBV ranks #7 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 5,690,502 $1,390,986,307
2 AZN
Astrazeneca PLC
 6,529,961 $1,287,838,906
3 MRK
Merck & Co., Inc.
 3,964,890 $476,936,615
4 LLY
ELI LILLY & Co
 504,764 $464,266,781
5 GILD
Gilead Sciences, Inc.
 3,094,227 $431,242,416
6 BMY
Bristol Myers Squibb Co
 6,879,864 $417,263,749
7 ABBV
AbbVie Inc.
This page 		1,393,938 $303,167,574
8 PFE
Pfizer Inc
 5,490,142 $154,163,186

All Filings in ABBV

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $303,167,574 1,393,938
2026-03-31 $27,969,214 128,600
2026-03-31 $18,617,144 85,600
2025-12-31 $287,719,862 1,259,223
2025-12-31 $23,465,923 102,700
2025-12-31 $19,947,177 87,300
2025-09-30 $17,573,886 75,900
2025-09-30 $372,627,045 1,609,342
2025-09-30 $26,812,332 115,800
2025-06-30 $18,933,240 102,000
2025-06-30 $12,380,854 66,700
2025-06-30 $285,041,783 1,535,620
2025-03-31 $335,052,858 1,599,145
2025-03-31 $25,687,152 122,600
2025-03-31 $19,192,032 91,600
2024-12-31 $19,991,250 112,500
2024-12-31 $354,419,803 1,994,484
2024-12-31 $11,745,970 66,100
2024-09-30 $14,100,072 71,400
2024-09-30 $23,026,168 116,600
2024-09-30 $480,743,728 2,434,392
2024-06-30 $12,538,112 73,100
2024-06-30 $9,587,968 55,900
2024-06-30 $354,229,103 2,065,235
2024-03-31 $892,290 4,900
2024-03-31 $1,839,210 10,100
2024-03-31 $317,577,480 1,743,973
2023-12-31 $224,374,396 1,447,857
2023-09-30 $180,727,497 1,212,448
2023-06-30 $175,899,982 1,305,574
2023-03-31 $243,662,066 1,528,908
2022-12-31 $238,082,881 1,473,194
2022-09-30 $236,647,390 1,763,262
2022-06-30 $616,721,559 4,026,649
2022-03-31 $710,418,704 4,382,325
2021-09-30 $471,886,482 4,374,585
2021-06-30 $459,211,764 4,076,809
2021-03-31 $463,637,529 4,284,213
2020-12-31 $518,237,509 4,836,561
2020-09-30 $405,237,761 4,626,530
2020-06-30 $465,993,598 4,746,319
2020-03-31 $331,127,834 4,346,080

Report a Problem

Category
Description
Email (optional, for follow-up)